Testing effectiveness (Phase 2)Ended earlyNCT03254927
What this trial is testing
CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Who this might be right for
Advanced Head and Neck Squamous Cell Carcinoma
Celldex Therapeutics 30